Market Access and Phase IV Solutions

Covance市场准入和第四阶段解决方案具有丰富的经验和前瞻性思维,可帮助您确保患者的安全和准入,同时最大限度地实现产品价值和商业成功。

No matter where your product is in its lifecycle, we work with you to maximize its clinical and commercial value. Over the last 30 years, Covance has established a complete, comprehensive portfolio of services to optimize patient support, adherence and product access, leveraging RWE and innovative Phase IV studies to demonstrate value, efficacy, and safety to payers, prescribers and regulatory bodies, as well as providing a world leading safety solutions portfolio. From the following broad categories, Covance builds flexible solutions to address the unique challenges of your products and therapy areas

在科文斯市场准入,我们从仔细倾听和了解您的需求开始。然后,我们应用我们的行业专业知识来开发对您的组织有意义的定制解决方案。

科文斯制药顾问在开会时的照片。
文件